Trademark: 85383694
Status Date
Monday, September 23, 2013
Filing Date
Thursday, July 28, 2011
Published for Opposition
Tuesday, December 27, 2011
Abandoned Date
Monday, September 23, 2013
5 Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
Oct 11, 2013
Teas Change Of Correspondence Received
Sep 23, 2013
Abandonment Notice Mailed - No Use Statement Filed
Sep 23, 2013
Abandonment - No Use Statement Filed
Feb 23, 2013
Notice Of Approval Of Extension Request E-Mailed
Feb 22, 2013
Extension 2 Granted
Feb 12, 2013
Extension 2 Filed
Feb 21, 2013
Case Assigned To Intent To Use Paralegal
Feb 12, 2013
Teas Extension Received
Jun 20, 2012
Notice Of Approval Of Extension Request E-Mailed
Jun 18, 2012
Extension 1 Granted
Jun 18, 2012
Extension 1 Filed
Jun 18, 2012
Teas Extension Received
Feb 21, 2012
Noa E-Mailed - Sou Required From Applicant
Dec 27, 2011
Official Gazette Publication Confirmation E-Mailed
Dec 27, 2011
Published For Opposition
Dec 7, 2011
Notification Of Notice Of Publication E-Mailed
Nov 18, 2011
Approved For Pub - Principal Register
Nov 18, 2011
Assigned To Examiner
Aug 2, 2011
New Application Office Supplied Data Entered In Tram
Aug 1, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
